Leukemia Clinical Trials

Showing 3461-3480 of 5,235 trials

Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT02337478

This pilot phase II trial studies how well vincristine sulfate liposome works in treating patients with acute myeloid leukemia that has returned after a period of improvement or has not responded to previous treatment. Drugs used in chemotherapy, such as vincristine sulfate liposome, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Liposomal encapsulation prolongs bioavailability (proportion of drug that enters the circulation when introduced into the body) of vincristine sulfate, and may increase its delivery to cancer cells with fewer side effects.

Recurrent Adult Acute Myeloid Leukemia

Wake Forest University Health Sciences5 participantsStarted Jun 2015

Winston-Salem, North Carolina, United States

COMPLETEDPhase 1

A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT02556892

The purpose of this study is to evaluate the safety of Ibrutinib in Japanese participants with treatment-naive chronic lymphocytic leukemia ( CLL) or small lymphocytic lymphoma (SLL).

Lymphocytic Leukemia

Janssen Pharmaceutical K.K.8 participantsStarted Jul 2015

Fukuoka, Japan • Hiroshima, Japan • Isehara, Japan +5 more locations

COMPLETEDNA

Comparison Between Local and Imported Skin Prick Testing Result of Rat and Mouse Allergen Extracts

NCT03645161

In respiratory allergy patients, skin prick test results of local rat and mouse allergen extracts are not significant different from imported ones

Allergic Rhinitis Due to Animal Hair and Dander

Mahidol University230 participantsStarted May 2018

Bangkok, Thailand

Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Comparison Between Local and Imported Skin Prick Testing Result of Rat and Mouse Allergen Extracts

Related Searches

The Emergency Department Stopping Elderly Accidents, Deaths and Injuries Program

The Patient Experience of a Paramedic-Pharmacist Referral Pathway for Clinical Medication Reviews

RGB(Red- Green-Blue) Measurement of the Nasal Mucosal Image

Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation

XLCART001 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy Subjects

Safety and Efficacy of Anti-CD123 CAR-T Therapy in Patients With Refractory/ Relapsed CD123+ Acute Myeloid Leukemia.

HAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human

Effect of Doxycycline on Cardiac Remodelling in STEMI Patients

Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children

Immune-Modulated Study of Selected Small Molecules (Gefitinib, AZD9291, or Selumetinib + Docetaxel) or a 1st Immune-Mediated Therapy (IMT; Tremelimumab) With a Sequential Switch to a 2nd IMT (MEDI4736) in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

PillCam SB3 Capsule- Feasibility Study

Intraoperative Spillage of Bile and Gallstones During Laparoscopic Cholecysetectomy

Penicillin Allergy Testing and Resensitization Rate

Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia

Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer

A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers